Two‐incision versus three‐incision implantation technique of subcutaneous implantable cardioverter defibrillator: Systematic review and meta‐analysis of 2076 patients

The implantable cardioverter‐defibrillator (ICD) was designed to detect and treat ventricular arrhythmias, which account for nearly half of all cardiovascular fatalities. Transvenous ICD (TV‐ICD) complications were reduced by introducing subcutaneous ICD (S‐ICD). S‐ICD can be implanted using a three (3IT)‐ or two (2IT)‐incision technique. This systematic review and meta‐analysis was conducted to compare the 3IT to the 2IT.

• Publication year

  2023

• Venue

  Pacing and clinical electrophysiology : PACE

• Publication date

  2023-12-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/pace.14902PMID 38071455
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outcomes of two versus three incision techniques: Results from the subcutaneous ICD post‐approval study

  2021cited by this paper
• EndNote 20 desktop version

  2021cited by this paper
• Characterization of Models for Identifying Physical and Cognitive Frailty in Older Adults With Diabetes: Systematic Review and Meta-Analysis

  2020cited by this paper
• Long‐term follow‐up of the two‐incision implantation technique for the subcutaneous implantable cardioverter‐defibrillator

  2020cited by this paper
• Understanding Outcomes with the S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative results.

  2019cited by this paper
• Multicentre experience with the second‐generation subcutaneous implantable cardioverter defibrillator and the intermuscular two‐incision implantation technique

  2019influential reference
• Prolonged Operative Duration Increases Risk of Surgical Site Infections: A Systematic Review

  2017cited by this paper
• Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.

  2017cited by this paper
• Implantation of the Subcutaneous Implantable Cardioverter-Defibrillator: An Evaluation of 4 Implantation Techniques

  2017influential reference
• Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results.

  2017cited by this paper
• Chapter-42 Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and effortless registry

  2016cited by this paper
• Rayyan—a web and mobile app for systematic reviews

  2016cited by this paper
• Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis.

  2015cited by this paper
• Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry.

  2015cited by this paper
• Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry

  2014cited by this paper
• Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator

  2013cited by this paper
• Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator.

  2013cited by this paper
• Sudden Cardiac Death Caused by Coronary Heart Disease

  2012cited by this paper
• The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort.

  2012cited by this paper
• An entirely subcutaneous implantable cardioverter-defibrillator.

  2010cited by this paper
• Performance of the St. Jude Medical Riata leads.

  2009cited by this paper
• Lead malfunctions in implantable cardioverter defibrillators: where are we and where should we go?

  2009cited by this paper
• Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices.

  2009cited by this paper
• Implantable cardioverter-defibrillators after myocardial infarction.

  2008cited by this paper
• Semper fidelis--consumer protection for patients with implanted medical devices.

  2008cited by this paper
• Prognostic importance of defibrillator shocks in patients with heart failure.

  2008cited by this paper
• Bmc Medical Research Methodology Open Access Development of Amstar: a Measurement Tool to Assess the Methodological Quality of Systematic Reviews

  2007cited by this paper
• Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators Over a Period of >10 Years

  2007cited by this paper
• Transvenous Pacing Leads and Systemic Thromboemboli in Patients With Intracardiac Shunts: A Multicenter Study

  2006cited by this paper

• Contemporary Issues in Implantable Cardioverter-Defibrillators: Personalising Device Therapy.

  2025cites this paper